
    
      The primary objective of this study is to evaluate the safety and tolerance of a rush build
      up administration of Depigoid forte pollen and the first maintenance dose administered 4
      weeks later. The treatment period consists, thus, of 4 weeks.

      Primary variable:

      â€¢Number of subjects [%] suffering at least one immediate or delayed systemic reaction of
      grade 2 or higher during the 4-weeks treatment period [grading according to the 2006 EAACI
      standards
    
  